These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1452 related articles for article (PubMed ID: 32800530)

  • 1. NK cells and ILCs in tumor immunotherapy.
    Sivori S; Pende D; Quatrini L; Pietra G; Della Chiesa M; Vacca P; Tumino N; Moretta F; Mingari MC; Locatelli F; Moretta L
    Mol Aspects Med; 2021 Aug; 80():100870. PubMed ID: 32800530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting Human NK Cells in Tumor Therapy.
    Vacca P; Pietra G; Tumino N; Munari E; Mingari MC; Moretta L
    Front Immunol; 2019; 10():3013. PubMed ID: 32010130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human NK cells: From surface receptors to clinical applications.
    Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
    Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation.
    Vacca P; Montaldo E; Croxatto D; Moretta F; Bertaina A; Vitale C; Locatelli F; Mingari MC; Moretta L
    Front Immunol; 2016; 7():188. PubMed ID: 27242795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.
    Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L
    Front Immunol; 2019; 10():910. PubMed ID: 31105707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.
    Sivori S; Vacca P; Del Zotto G; Munari E; Mingari MC; Moretta L
    Cell Mol Immunol; 2019 May; 16(5):430-441. PubMed ID: 30778167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells.
    Morandi F; Yazdanifar M; Cocco C; Bertaina A; Airoldi I
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?
    Vacca P; Munari E; Tumino N; Moretta F; Pietra G; Vitale M; Del Zotto G; Mariotti FR; Mingari MC; Moretta L
    Immunol Lett; 2018 Sep; 201():14-19. PubMed ID: 30439479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment.
    Bahmanyar M; Vakil MK; Al-Awsi GRL; Kouhpayeh SA; Mansoori Y; Mansoori B; Moravej A; Mazarzaei A; Ghasemian A
    BMC Cancer; 2022 Nov; 22(1):1220. PubMed ID: 36434591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
    Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
    Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.
    Jan CI; Huang SW; Canoll P; Bruce JN; Lin YC; Pan CM; Lu HM; Chiu SC; Cho DY
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.
    Mehta RS; Rezvani K
    Front Immunol; 2018; 9():283. PubMed ID: 29497427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helper Innate Lymphoid Cells-Unappreciated Players in Melanoma Therapy.
    Garofalo C; Cerantonio A; Muscoli C; Mollace V; Viglietto G; De Marco C; Cristiani CM
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy.
    Rethacker L; Roelens M; Bejar C; Maubec E; Moins-Teisserenc H; Caignard A
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.
    Davis ZB; Vallera DA; Miller JS; Felices M
    Semin Immunol; 2017 Jun; 31():64-75. PubMed ID: 28882429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.
    Zaghi E; Calvi M; Di Vito C; Mavilio D
    Front Immunol; 2019; 10():2794. PubMed ID: 31849972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of human natural killer cells and other innate lymphoid cells.
    Montaldo E; Vacca P; Moretta L; Mingari MC
    Semin Immunol; 2014 Apr; 26(2):107-13. PubMed ID: 24559836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells in the treatment of high-risk acute leukaemia.
    Locatelli F; Moretta F; Brescia L; Merli P
    Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
    Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity.
    Rafei H; Daher M; Rezvani K
    Br J Haematol; 2021 Apr; 193(2):216-230. PubMed ID: 33216984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.